SEPTEMBER 25-26, 2024, NEWARK, NJ
Agenda
Displaying agenda in the event’s time zone (EDT, UTC -4)
Registration and Networking Breakfast
Sense Making with AI in the Data Age
This Masterclass on Sense Making with AI offers a comprehensive exploration into leveraging artificial intelligence (AI) tools and methodologies to extract valuable insights, make informed decisions, and navigate complexity with clarity.
Developed by industry experts and thought leaders at the forefront of AI innovation, this Masterclass delves into the intersection of human cognition and machine intelligence. Participants will embark on a journey to understand how AI technologies can augment human capabilities in sense making, enabling them to unravel intricate patterns, detect trends, and glean actionable intelligence from data-rich environments.
Presented by Atacana Group
Refreshment Break
Synthesizing Primary Research Into Actionable Insights and Presentations
Presented by Molekule
Networking Lunch
KITting and KIQing: Key Intelligence Topics and Questions- Asking the right questions will provide critical insight to your business
Presented by Lifescience Dynamics
Refreshment Break
Developing a Competitive Activity Framework to enhance organizational competitiveness
This workshop session, will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS' in-house proprietary methodologies.
Key to this session will be addressing business needs across the lifecycle, whereby participants will:
• Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
• Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
Receive hands-on opportunities to apply learnings to a pharma case study in a learning environment
• Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.
Presented by INOVIS
Refreshment Break
Learn how to ‘GameStorm’ and become familiar with the giants of competitive analysis models and frameworks
• VUCA –focusing specifically on the concept of the competitive “Why?”
• Scenario Planning
• Porters Five Forces Explained
• Porters Four Corners Explained
• Blindspot Analytical Framework
Presented by Dig Worldwide
Masterclasses Conclude
Registration & Networking Breakfast in Exhibition Hall
Chairperson’s Opening Remarks
Presented by Johnson & Johnson
Keynote: Inflation Reduction Act
Presented by PhRMA
Keynote: The Importance of Early Strategic Planning For Global Success
At its core, it is critical for pharma companies to keep their global commercial strategies in mind way ahead of commercial launch and integrate them into the R&D pipeline programs at every step.
In today’s complex healthcare ecosystem when the local regulatory authorities have numerous nuances, it is important to think beyond the regulatory and clinical trial perspective to improve a product’s probability of success in the global markets. Investing in product planning at very early stages has earned greater prominence in recent years. Through this session, we would like to share Molekule Consulting’s perspectives on the key factors to success to win the global markets.
Presented by Molekule Consulting
Networking & Refreshments in Exhibition Hall
Keynote: China and emerging markets as growing players in Pharma
Presented by Lifescience Dynamics and Pfizer
Keynote: Executive Level Boardroom Discussions
Presented by Abbott, AbbVie, BioMarin, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Johnson & Johnson, and Novartis Institutes for BioMedical Research
“Ask the Experts” Interactive Round Tables
ROUNDTABLE 1
Creating a Cross-brand / Therapeutic Area CI Approach
Presented by Ferring
ROUNDTABLE 2
Precision in Disease Epidemiology Estimation: Mastering the Craft
Presented by Astellas
ROUNDTABLE 3
Delivering on KITs/KIQs vs. Objectives vs. Valued Contributions
Presented by MorphoSys
ROUNDTABLE 4
Leveraging CI Input & Analysis to Support Key Investment Decisions Across the Portfolio
Presented by Ipsen
ROUNDTABLE 5
AI Powered CI: Now a Reality
Experience speed and efficiency of an AI powered command center that generates real-time Insights, reduces costs, and democratizes information across enterprise functions.
Presented by PharmaEdge
ROUNDTABLE 6
TBD
Networking Luncheon
TRACK A
Is My AI Better than your AI?
There is no match for human curiosity and our ability to frame a key intelligence question (KIQ) that has the potential to allow one competitor to gain an edge over another.
Dig Worldwide’s talk will delve into why human intelligence will always persist as an essential component in the pursuit of competitive advantage. Tony Nagle and Beth Elliott Co-Founders of Dig Worldwide will present a primary intelligence practitioners view on:
• How is AI changing competitive intelligence?
• Why Human Intelligence will always be irreplaceable by AI?
• Their thoughts on a “Golden Mean”
Presented by Dig Worldwide
TRACK B
Help for Generative AI?! The Need for Proprietary Machine Learning When Summarizing News Alerts
Context counts. FENIX will show why training mainstream generative AI to an organization’s content lens is a critical success factor for creating the perception of value exchange.
The laborious task of creating concise, yet accurate news summaries is a perfect pairing for proprietary machine learning with mainstream generative AI. Don’t miss this session if you think CI should be conversing with your organization’s digital transformation stakeholders.
Presented by Fenix Group International
TRACK C
The State of the Biopharmaceutical Industry
As the biopharmaceutical industry is resiliently recovering from the challenges presented by the pandemic, the recovery has been already overshadowed by a range of macroeconomic and geopolitical factors.
The issues with supply-demand imbalance, inflation, market volatility and geopolitical tensions & conflicts continue to pose a degree of instability and challenges for economic recovery and growth prospects. Although the pharmaceutical industry is often viewed as recession-proof, it is not immune to future challenges. Ongoing drug pricing and reimbursement constraints, regulatory challenges, pressures to innovate, increased competition, as well as biotech funding instability will continue to test the biopharmaceutical industry in the coming years. In The State of the Biopharmaceutical Industry discussion, GlobalData will highlight what we see are the factors impacting business environment and key trends that are going to shape the biopharmaceutical industry in 2025 and beyond.
Presented by GlobalData Healthcare
TRACK A
The Evolution of CI Beyond the Brand
• Typical CI methodologies and planning window• The forces at work in the healthcare marketplace (2030+)
• How to project the future marketplace of 2030+ with increased confidence
Presented by Ionis
TRACK B
The Appropriate use of AI Capabilities in Intelligence Groups: Striking the Right Balance Between AI/ML and CI Analysist Intuition
Presented by Lilly
TRACK C
Bending Without Breaking: Maintaining CI Excellence in a Season of Shrinking Budgets
When times are tough and budgets are tight, how do you flex and adapt to continue meeting stakeholder needs? Through a series of case studies and anecdotes, we’ll have a discussion on best practices for doing great work without stressing (too much) over funding.
Presented by Bristol Myers Squibb
TRACK A
AI-Enabled Continuous Monitoring: Enhancing Accuracy, Speed, and Strategic Insights
Discover how AI is revolutionizing the Continuous Monitoring process, by providing efficiencies through automation, exponential scale through rapid data processing, and surfacing insights for better decision making.
Presented by DataZymes
TRACK B
How Pharmas Use Generative AI for Competitive Intelligence Research
Pharmaceutical companies are some of the world's most technologically sophisticated enterprises, so it's not surprising they're at the vanguard of using generative AI. One early application is for mining market and competitive intelligence research. In this session, learn how leading drug development companies are employing GenAI to instantly derive insights from vetted credible sources to inform their product development, strategy and marketing decisions.
Presented by Northern Light
TRACK C
Life Sciences CI Survey: Insights from Sedulo Group
Learn how your peers navigate the constantly changing CI landscape and gain valuable benchmarks and insights to enhance your CI strategies. You’ll see data gathered from 109 survey responses across 90 life sciences companies.
This comprehensive survey analyzes competitive intelligence (CI) practices, challenges, and trends within the life sciences sector.
Session Highlights:
• Explore CI Practices and Trends
• Benchmarking CI Structures and Approaches
• Understand Peer Challenges and Solutions
• Discover Vendor Vetting and Engagement Strategies
• Uncover Future Perspectives on Life Sciences CI
Presented by Sedulo Group
Networking & Refreshments in Exhibition Hall
TRACK A
Leveraging Intelligence to Inform Innovation Strategy
Research and analysis are the fundamental building blocks behind any innovation. They're essential for discovering unmet needs, learning what is or isn't already in the marketplace, gaining input on how to differentiate, and assessing the feasibility of a successful market entrance with an innovative product or service.
This session will share practical examples of how CI researchers/analysts help solve innovation team challenges around deciding where to invest and divest. and outline the key action steps to building a mutually beneficial relationship with Innovation teams to formulate effective Innovation strategies.
Objectives:
• Learn how research functions can best collaborate with an Innovation team
• Understand the kinds of insight most helpful for Innovation Labs
• Gain input on the integration of market, customer, and competitive research
• Acquire tips on how to foster engaging conversations that drive action to create strategies
• Apply best practices to support Innovation
Presented by Proactive Worldwide
TRACK B
Optimizing the Strategic Value of Cross-Functional Competitive Intelligence
CI leaders are charged with supporting stakeholders across all functions and across assets from early-to-late stage. This breadth of oversight often stretches CI leader capacity and can unintentionally promote transactional arrangements with internal stakeholders. Today, we’ll discuss how to strengthen cross-functional CI workflows and relationships, improve research efficiency and optimize methodology, all towards the goal of strengthening the strategic value of the CI.
Presented by Norstella
TRACK C
Pharma CI in the Post-covid Era: Remote Workers, Offshore Operations, and the Integration of AI
Navigating from disjointed to optimized and seamless, and key learnings from pharma and consulting.
Presented by Deallus
TRACK A
Complexities in Working with Alliances
Presented by Legend Biotech
TRACK B
Increasing & Maximizing the Predictive Value of CI
Presented by Bristol Myers Squibb, CorMedix, Regeneron Pharmaceuticals, and Takeda Pharmaceuticals
TRACK C
How to be an Influencer of Strategic Decisions
Presented by Dewpoint Therapeutics, Eisai, Merck, Sanofi, and Vir Biotechnology
Cocktail Reception & Networking
Registration & Networking Breakfast in Exhibition Hall
TRACK A
How to antiCIpate competitive moves and deliver intelligence that aCtIvates
Presented by AbbVie, Intuitive, and Precision
TRACK B
Macro Trends in Pharma and Biotech, and its Impact
Presented by AbbVie, BioMarin, InPhronesis and Janssen
TRACK C
Elevating CI as an Invaluable Partner for Brand Teams
Presented by AbbVie and Vertex
TRACK A
How to Conduct Competitive Simulation Workshops Effectively and Efficiently: Lessons From Industry
Competitive simulation workshops are a powerful and diverse tool at the disposal of any CI function. In this presentation we will outline the basic elements that are key to any successful CI workshop. Using examples from our experiences at Servier, and in collaboration with our vendors Lifescience Dynamics, we will describe some recent successes we’ve had in conducting CI workshops with minimal notice but maximum impact and value.
Presented by Lifescience Dynamics and Servier
TRACK B
Generative AI for Competitive Intelligence
• Combining AI and human intelligence• Case studies for insight gathering, summarization, and sentiment assignment
• Efficient information management for congress planning and beyond
Presented by LARVOL
TRACK C
CI’s New Parameters: Mapping the Impact of Emerging Hot Topics
Adding new parameters to CI programs can help with differentiation and benchmarking…or they can simply create noise.
Join Trinity Life Sciences as we sort through globally hot topics such as AIML, DEI and environmental impact to answer the questions:
What hot topic is the competition focused on?
Why should you include these as part of your long-term strategy?
Where can you differentiate?
Which of these topics can be dismissed for now?
Presented by Trinity Life Sciences
Networking & Refreshments in Exhibition Hall
TRACK A
Are Disruptors Disrupting Your Strategy?
With the pace of innovations coming online, disruptors are fundamentally evolving and altering the competitive landscape and our ways of working. As the rate of change increases, pharma and healthcare companies must identify and deploy resilient strategies that not only withstand but, more importantly, capitalize on emerging opportunities. Join us as we examine some of the most poignant disruptors. We will also explore the tools and methods CI/MI practitioners use to better predict, adjust, and even enhance strategies to stay competitive.
Presented by Fletcher
TRACK B
Predicting Drug Approvals: A Neural Network Approach
Neural networks, when combined with Kognitic’s AI NLPs, can analyze vast clinical trial datasets to identify the patterns within. Kognitic has developed a revolutionary, deep-learning model to predict drug launch dates, factoring in dynamic factors, such as protocol changes. Discover how Kognitic empowers our partners' CI decision-making.
Presented by Kognitic
TRACK C
Optimal Integration of Data, Tech and Subject Matter Expertise: Our Approach to Clinical and Regulatory Timeline Prediction
Order of entry and the speed to market significantly impact the market share that our clients can stake claim to. To ensure that our clients are ahead of the curve and have a sustained competitive advantage we help them be better and faster at understanding the competitive clinical and regulatory timelines. This allows our clients to remain informed and helps them make decisions proactively. Our 'Prescient' approach to clinical and regulatory timeline prediction brings you an objective, evidence-based answer that combines the best of data automation, visualisation, analytics and intelligence of our subject matter experts.
Presented by Prescient
“Ask the Experts” Interactive Round Tables
ROUNDTABLE 1
Creating a Cross-brand / Therapeutic Area CI Approach
Presented by Ferring
ROUNDTABLE 2
Precision in Disease Epidemiology Estimation: Mastering the Craft
Presented by Astellas
ROUNDTABLE 3
Delivering on KITs/KIQs vs. Objectives vs. Valued Contributions
Presented by MorphoSys
ROUNDTABLE 4
Leveraging CI Input & Analysis to Support Key Investment Decisions Across the Portfolio
Presented by Ipsen
ROUNDTABLE 5
TBD
ROUNDTABLE 6
TBD
Networking Luncheon
Announcement of Raffle Prize Winners
Keynote: Generics & Biosimilars – Important Learnings from Real World Case Studies
This session highlights innovative approaches leveraged by generic and biosimilars to speed up market entry. Specifically, this presentation will enable you to
1. Advance your understanding of core regulatory routes, timelines and strategies
2. Understand core Gx/biosimilar product development and entry strategies
3. Learn from & set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual approaches
Presented by INOVIS
Keynote: Futureproof Your Commercial Strategy with AI and Human Expertise to Overcome Uncertainty
• Explore how the combination of AI augmentation and human expertise is revolutionizing agile, cross-functional decision-making
• Work with future-looking insights from real-time data streams to sidestep hidden pitfalls to ensure long-term success
Presented by Atacana Group
Keynote: Hey FENIX, We Need Better CI Tools, Can Genny Help?
In 2023, FENIX unveiled two of its tech offerings - HeyFENIX and Project Genny.
In this session, FENIX will provide a new update from 2023 about our latest tools for enhancing CI workflows using natural language processing (NLP) and a contextually trained generative AI model. Importantly, both solutions match stakeholder behaviors and are simple to integrate. FENIX will focus on the stakeholder archetypes that benefit most and how our technology aligns with their business objectives. Finally, FENIX will demonstrate how these vital integrations can optimize asynchronous CI data retrieval and realize all efficiencies imaginable.
Presented by Fenix Group International
A Look Forward: Summary & Key Takeaways
Presented by Abbott, AbbVie, BioMarin, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Johnson & Johnson, and Novartis Institutes for BioMedical Research